Samsara Bio Capital, LLC Portfolio Holdings

Samsara Bio Capital, LLC

  • $217 Million
  • Q1 2025

Samsara Bio Capital, LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $217 Million distributed in 37 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Scholar Rock Holding Corp with a value of $180M, Arcellx, Inc. with a value of $8.87M, Rhythm Pharmaceuticals, Inc. with a value of $7.32M, Nkarta, Inc. with a value of $6.93M, and Gossamer Bio, Inc. with a value of $6.74M.

Examining the 13F form we can see an decrease of $110M in the current position value, from $326M to 217M.

Samsara Bio Capital, LLC is based out at Palo Alto, CA

Below you can find more details about Samsara Bio Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $217 Million
Healthcare: $216 Million

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 37
  • Current Value $217 Million
  • Prior Value $326 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 2 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Samsara Bio Capital, LLC Portfolio

Follow Samsara Bio Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samsara Bio Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email